Terapio

company

About

Terapio is a biopharmaceutical company developing therapeutics based on the RLIP76 protein.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$1.70M
Industries
Biopharma,Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2005
Number Of Employee
1 - 10
Operating Status
Active

Terapio is developing a pipeline of therapies based on the normally-occurring transport protein RLIP76 that moves free-radical toxins out of cells before significant damage can occur. Although naturally present in cells, increasing the amount of this protein available to normal cells affords them an even greater ability to deal with toxins from a variety of sources, including chemicals and radiation.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.70M
Terapio has raised a total of $1.70M in funding over 2 rounds. Their latest funding was raised on Jun 18, 2008 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 18, 2008 Series Unknown $1.70M 1 Texas Wide Open for Business Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Terapio is funded by 1 investors. Texas Wide Open for Business are the most recent investors.
Investor Name Lead Investor Funding Round
Texas Wide Open for Business Yes Series Unknown